Overview

Alfred Goodman Gilman (July 1, 1941 – December 23, 2015) was an American pharmacologist and biochemist best known for his discovery of G‑proteins, a family of intracellular proteins that relay signals from cell surface receptors to internal effectors. His work established a central mechanism by which hormones, neurotransmitters and sensory stimuli control cellular responses, and it earned him the 1994 Nobel Prize in Physiology or Medicine, shared with Martin Rodbell.

Discovery and scientific significance

In studies of how cells respond to extracellular signals, Gilman identified G‑proteins as the molecular switches that couple activated receptors to enzymes and ion channels inside the cell. These proteins bind guanosine nucleotides (GTP and GDP) and cycle between active and inactive states, thereby regulating many physiological processes such as metabolism, growth, sensory perception and synaptic transmission. The G‑protein concept unified a range of biochemical observations and created a framework for later work on receptor structure, second messengers and signal cascades. The term "G‑protein" refers to their dependence on GTP.

Career and legacy

Gilman combined laboratory research with academic leadership and mentoring. He spent much of his career in medical research institutions and helped build departments of pharmacology that emphasized molecular approaches to disease. His findings reshaped pharmacology because many drugs act by modulating G‑protein‑coupled receptor (GPCR) pathways, making these systems among the most important therapeutic targets in medicine. Gilman's family also had deep ties to pharmacology: his father was co‑author of the influential textbook commonly known to students and practitioners.

Impact and applications

  • Explained how hormones and neurotransmitters produce intracellular responses through GTP‑binding proteins.
  • Provided a mechanistic basis for the study and classification of G‑protein‑coupled receptors (GPCRs), now the largest class of drug targets.
  • Influenced research across endocrinology, neuroscience, immunology and cancer biology by revealing a common signaling currency.

Notable facts and death

For the significance of his discovery, Gilman and Rodbell were jointly awarded the Nobel Prize in 1994. His work remains foundational in both basic biology and in the development of medicines that act on GPCR pathways. Alfred G. Gilman died of pancreatic cancer in Dallas, Texas, on December 23, 2015, at the age of 74.

Further reading and historical context are available through scientific reviews and institutional memorials that summarize his experimental approach and lasting influence on modern pharmacology and cell biology. For concise background on related areas, see resources on G‑protein signaling and GPCR pharmacology.

Related topics and resources: G‑proteins, receptor signaling, drug development and Nobel Prize laureates in physiology or medicine.